Effects of consumption of the test food on skin of healthy Japanese wome
- Conditions
- Healthy Japanese subjects
- Registration Number
- JPRN-UMIN000044611
- Lead Sponsor
- ORTHOMEDICO Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 14
Not provided
Subjects (who) 1. are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction 2. have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. have been diagnosed with atopic dermatitis 5. use or take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage in daily 6. currently taking medications (including herbal medicines) and supplements 7. allergic to medications and/or the test-food-related products (especially rice bran) 8. have got cosmetic surgery 9. habitually receive skincare treatment (e.g., aesthetic treatment) or use instruments for beauty treatment (e.g., facial treatment device) 10. use any other products except for cosmetic creams, beauty essence, all-in-one cosmetic makeup, and face masks, skin lotions, milky lotions, and sunscreen, for daily skincare 11. lifestyle is not constant and may change during test period (e.g., night shifts, business trip, travel) 12. have been overexposed to the sun within the last month, are going to be overexposed to the sun without protection, or can not prevent sunburn during this trial (from the agreement to participate in this trial to the final test) 13. plan to have surgery from first consumption to two weeks after last consumption 14. are pregnant, lactation, or planning to become pregnant 15. have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 16. are judged as ineligible to participate in the study by the physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. The measured values of scoring of R7* at 12 weeks after consumption (12w)
- Secondary Outcome Measures
Name Time Method